Sector Chart Atossa Therapeutics, Inc.

Stocks

ATOS

US04962H7044

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 18:24:04 31/07/2026 +04			5-day change	1st Jan Change
2.150 ^USD	-1.83%		-8.50%	-76.27%

07-28	Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in Er-Positive Breast Cancer	CI
06-29	Atossa Therapeutics, Inc.(NasdaqCM:ATOS) added to Russell Microcap Value Benchmark Index	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
ATOSSA THERAPEUTICS, INC.	18.86M	-	-	-	-	-
LONZA GROUP AG	49.37B
IQVIA HOLDINGS INC.	39.14B
REVOLUTION MEDICINES, INC.	40.85B	-	-	-	-	-
BEONE MEDICINES AG	35.81B
CELLTRION, INC.	30.5B